Fidelity Investments
FLGT icon

Fidelity Investments’s Fulgent Genetics FLGT Stock Holding History

Fidelity Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Buy
1,100
+310
+39% +$5.25K ﹤0.01% 4625
2026
Q1 		$12.6K Sell
790
-3,191
-80% -$69.3K ﹤0.01% 4690
2025
Q4 		$105K Sell
3,981
-7,323
-65% -$190K ﹤0.01% 3737
2025
Q3 		$255K Sell
11,304
-268
-2% -$5.52K ﹤0.01% 3261
2025
Q2 		$230K Buy
11,572
+10,409
+895% +$203K ﹤0.01% 3258
2025
Q1 		$19.7K Sell
1,163
-3,135
-73% -$53.4K ﹤0.01% 4227
2024
Q4 		$79.4K Buy
4,298
+1,842
+75% +$36K ﹤0.01% 3651
2024
Q3 		$53.4K Sell
2,456
-953
-28% -$21.3K ﹤0.01% 3756
2024
Q2 		$66.9K Buy
3,409
+2,085
+157% +$43.5K ﹤0.01% 3468
2024
Q1 		$28.7K Sell
1,324
-67
-5% -$1.66K ﹤0.01% 3858
2023
Q4 		$40.2K Buy
1,391
+282
+25% +$7.54K ﹤0.01% 3612
2023
Q3 		$29.7K Sell
1,109
-84
-7% -$2.87K ﹤0.01% 3606
2023
Q2 		$44.2K Sell
1,193
-671
-36% -$23.4K ﹤0.01% 3486
2023
Q1 		$58.2K Buy
1,864
+825
+79% +$26.6K ﹤0.01% 3389
2022
Q4 		$30.9K Sell
1,039
-26,936
-96% -$964K ﹤0.01% 3621
2022
Q3 		$1.07M Buy
27,975
+5,409
+24% +$271K ﹤0.01% 2589
2022
Q2 		$1.23M Buy
22,566
+6,041
+37% +$332K ﹤0.01% 2621
2022
Q1 		$1.03M Buy
16,525
+16,271
+6,406% +$1.07M ﹤0.01% 2783
2021
Q4 		$25K Sell
254
-12
-5% -$1.05K ﹤0.01% 3403
2021
Q3 		$24K Sell
266
-49
-16% -$4.45K ﹤0.01% 3384
2021
Q2 		$29K Buy
315
+115
+58% +$9.18K ﹤0.01% 3281
2021
Q1 		$19K Sell
200
-40,051
-100% -$4.13M ﹤0.01% 3258
2020
Q4 		$2.1M Buy
+40,251
New +$1.68M ﹤0.01% 2389
2020
Q1 		– Sell
-50
Closed -$1K – 3819
2019
Q4 		$1K Buy
+50
New +$594 ﹤0.01% 3642

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's FLGT Position: Q2 2026 in Review

Fidelity Investments increased its Fulgent Genetics (FLGT) stake by 39% in Q2 2026, buying an estimated $5.25K and bringing the position to 1,100 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4625.

Fidelity Investments first reported a position in FLGT in Q4 2019 and has held it in 24 quarters since. The position peaked at $2.1M in Q4 2020. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Fidelity Investments held 1,100 shares of Fulgent Genetics worth $22.6K as of Q2 2026.
  • Fidelity Investments bought 310 Fulgent Genetics shares in Q2 2026, an estimated $5.25K.
  • Fulgent Genetics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4625 holding.
  • Fidelity Investments first reported a position in Fulgent Genetics in Q4 2019 and has held it in 24 quarters since.
  • Fidelity Investments's Fulgent Genetics position peaked at $2.1M in Q4 2020.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.